Epygenix Therapeutics is a precision medicine-based biopharmaceutical company focused on discovering and developing drugs that treat Dravet syndrome (DS) and other genetic epilepsies.
View Top Employees from Epygenix Therapeutics, Inc.Website | http://www.epygenix.com |
Revenue | $6 million |
Employees | 6 (3 on RocketReach) |
Founded | 2016 |
Address | 140 E Ridgewood Ave Ste 415, Paramus, New Jersey 07652, US |
Phone | (201) 940-7377 |
Fax | (201) 940-7218 |
Technologies |
JavaScript,
HTML,
PHP
+17 more
(view full list)
|
Industry | Biotechnology Research, Manufacturing General, Biopharma, Manufacturing, Biotechnology, Health Care, Science and Engineering, Pharmaceutical |
SIC | SIC Code 28 Companies, SIC Code 283 Companies |
NAICS | NAICS Code 325 Companies, NAICS Code 32541 Companies, NAICS Code 3254 Companies, NAICS Code 32 Companies |
Looking for a particular Epygenix Therapeutics, Inc. employee's phone or email?
The Epygenix Therapeutics, Inc. annual revenue was $6 million in 2024.
Mike Landis is the CFO of Epygenix Therapeutics, Inc..
3 people are employed at Epygenix Therapeutics, Inc..
Epygenix Therapeutics, Inc. is based in Paramus, New Jersey.
The NAICS codes for Epygenix Therapeutics, Inc. are [325, 32541, 3254, 32].
The SIC codes for Epygenix Therapeutics, Inc. are [28, 283].